- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04876885
The Future of Viral Communications: Video-Based Health Promotion Strategies for COVID-19 Vaccinations
7. mai 2021 oppdatert av: Sarrah Lal, McMaster University
The investigators aim to study whether education, in the form of three two-minute educational videos about COVID-19 vaccine development and dissemination, reduces vaccine hesitancy and increases intent to vaccinate.
The investigators intend to use insights from this research study to develop a framework for video-based 'education prescriptions' that reduce vaccine hesitancy and increase intent to vaccinate across a number of infectious diseases.
This may have wide-ranging impact: inform practice for health promotions and public health, as well as support infectious disease related work done by healthcare professionals (e.g.
those working in travel medicine, where vaccination rates are also low).
Studieoversikt
Status
Har ikke rekruttert ennå
Intervensjon / Behandling
Detaljert beskrivelse
The World Health Organization listed vaccine hesitancy as one of the leading threats to global health in 2019.
Vaccine hesitancy is defined as the "reluctance or refusal to vaccinate despite the availability of vaccines".
Given the novelty of the COVID-19 pandemic, hesitancy towards use of COVID-19 vaccine may be linked to the process of vaccine development and clinical trial validation of safety and/or efficacy, rather than hesitations regarding vaccines in general.
This has already inspired several education campaigns.
It is unclear whether education leads to reduced hesitance and whether reduced hesitance leads to increased intent to vaccinate.
Further, early surveys demonstrating high COVID-19 vaccine acceptance and intent to vaccinate may not reflect actual uptake, as shown by comparisons to flu vaccination uptake at a time when flu vaccines are both available, validated and largely freely accessible.
Inspiring vaccine confidence is a multifaceted challenge, and the COVID-19 pandemic has shed light on one of its aspects, specifically the public health approach to health information dissemination.
The lack of evidence-based knowledge and preparedness coupled with pandemic fatigue impacts the uptake of recommended health behaviours and puts human lives at risk.
Different people adopt different responses to health promotion materials based on a variety of socioeconomic factors.
For example, in an American study on vaccination in children, it was found that children who had never received a vaccine tended to come from affluent, college educated families, while those who had only received some recommended vaccinations came from minority families that were single parent, low-income and less likely to have completed higher education.
Almost 50% of the parents of the unvaccinated children cited concerns about vaccine safety.
The strength of beliefs leading to hesitancy may change the ability to affect intent to vaccinate.
These beliefs may be contributed to by cultural dimensions in Canada and cultures of recently immigrated individuals, with regards to individualism, collectivism, perceptions of social benefits, etc.
These factors might also impact the choice to vaccinate.
The existence of many outlets for highly varied information underscores the need for unbiased and credible education on COVID-19 vaccinations.
The investigators aim to study whether education, in the form of three two-minute educational videos about COVID-19 vaccine development and dissemination, reduces vaccine hesitancy and increases intent to vaccinate.
The investigators intend to use insights from this research study to develop a framework for video-based 'education prescriptions' that reduce vaccine hesitancy and increase intent to vaccinate across a number of infectious diseases.
This may have wide-ranging impact: inform practice for health promotions and public health, as well as support infectious disease related work done by healthcare professionals (e.g.
those working in travel medicine, where vaccination rates are also low).
Studietype
Intervensjonell
Registrering (Forventet)
100
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Sarrah M Lal, MBA
- Telefonnummer: 289.808.8597
- E-post: lals2@mcmaster.ca
Studer Kontakt Backup
- Navn: Faith L Maelzer, BHSc
- Telefonnummer: 416.576.1714
- E-post: maelzerf@mcmaster.ca
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
16 år og eldre (Barn, Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
For the general public arm:
- An understanding of the English language at a grade 8 written level
- Reside in Ontario
For the healthcare professionals and public health professionals arm:
- Licensed to practice as a healthcare professional in Ontario
- An understanding of the English language at a grade 8 written level
- Reside in Ontario
Exclusion Criteria:
- Any individuals under age 16
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Annen: General public
The individuals recruited to the study will include those who are age 16 and older.
Due to recruitment feasibility we will focus efforts on individuals living in Ontario.
We intend to recruit individuals from COVID-19 assessment centres that are partnering in our study as well as through social media posts (Facebook, Twitter, LinkedIn).
|
Three two-minute educational videos about COVID-19 vaccine development and dissemination
|
|
Annen: Healthcare professionals and public health professionals
The individuals recruited to the study will include healthcare professionals and public health professionals impacted by infectious disease outbreaks.
Social media will be used to disseminate surveys to physicians, nurses, nurse practitioners, pharmacists, and healthcare workers.
Public health units will disseminate surveys to their workforce.
|
Three two-minute educational videos about COVID-19 vaccine development and dissemination
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of participants indicating intent to vaccinate against COVID-19
Tidsramme: One month
|
The primary end point of the study is "intent to vaccinate against COVID-19" within the general public survey.
We are looking for an increase in intent to vaccinate after the educational videos are completed.
This is a yes/no answer choice.
A change in response may be indicative of the impact of education on vaccination intent.
|
One month
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in score regarding vaccine hesitation after exposure to educational materials
Tidsramme: One month
|
The study seeks to understand whether providing video-based educational materials yields a positive change in score regarding vaccine hesitation (at least one point decrease) after exposure to educational materials.
A change in score may indicate that educational materials support a decrease in COVID-19 vaccination hesitancy in the population.
The scale title will be "Level of concern about the COVID-19 vaccine".
Values will range from 1-5, where 1 indicates no concern and 5 indicates high concern.
|
One month
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Sarrah M Lal, MBA, McMaster University
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020 Sep;26:100495. doi: 10.1016/j.eclinm.2020.100495. Epub 2020 Aug 12.
- Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020 Apr;35(4):325-330. doi: 10.1007/s10654-020-00634-3. Epub 2020 Apr 22.
- Dodd RH, Cvejic E, Bonner C, Pickles K, McCaffery KJ; Sydney Health Literacy Lab COVID-19 group. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021 Mar;21(3):318-319. doi: 10.1016/S1473-3099(20)30559-4. Epub 2020 Jun 30. No abstract available.
- Edwards B, Biddle N, Gray M, Sollis K. COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population. PLoS One. 2021 Mar 24;16(3):e0248892. doi: 10.1371/journal.pone.0248892. eCollection 2021.
- Sherman SM, Smith LE, Sim J, Amlot R, Cutts M, Dasch H, Rubin GJ, Sevdalis N. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621. doi: 10.1080/21645515.2020.1846397. Epub 2020 Nov 26.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Forventet)
6. mai 2021
Primær fullføring (Forventet)
6. juni 2021
Studiet fullført (Forventet)
6. juni 2021
Datoer for studieregistrering
Først innsendt
3. mai 2021
Først innsendt som oppfylte QC-kriteriene
3. mai 2021
Først lagt ut (Faktiske)
7. mai 2021
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
11. mai 2021
Siste oppdatering sendt inn som oppfylte QC-kriteriene
7. mai 2021
Sist bekreftet
1. mai 2021
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 12902
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .